SEC Form 4 · accession 0001179110-16-018548
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Mendlein
Director
Period of report
Feb 3, 2016
Accepted (ET)
Feb 4, 2016 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.00 | Feb 3, 2016 | A | 96,153 | A | — | Feb 2, 2026 | Common Stock | 96,153 | 96,153 | D |
Explanation of responses
- F1This option was granted on February 3, 2016 and is scheduled to vest over three years in equal monthly installments of 1/36th of the shares beginning on February 24, 2016 through January 24, 2019.